ankaferd blood stopper

Botanicalexperimental

Clinical trial activity

3 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
1

Earliest trial started Jun 1, 2021 (NCT05438771)

Timeline

2020s

  1. Jan 1, 2023

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06490653Phase 4Oct 31, 2024Ankara Yildirim Beyazıt University
NCT06457360Early Phase 1 (Phase 1)Nov 15, 2023British University In Egypt
NCT05438771N/AJun 1, 2021Uludag University
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Ankara Yildirim Beyazıt UniversityAcademic/Hospital1112024
British University In EgyptAcademic/Hospital1112023
Uludag UniversityAcademic/Hospital1112021
3 organizations
Page 1 / 1